EX-99.2 3 bion_ex992.htm UNAUDITED FINANCIAL STATEMENTS bion_ex992.htm

EXHIBIT 99.2

 

CHEMREX CORPORATION SDN. BHD.

 

INDEX TO THE UNAUDITED INTERIM FINANCIAL STATEMENTS

 

9 MONTHS ENDED SEPTEMBER 30, 2020

 

TABLE OF CONTENTS

 

 

 

Page

 

 

 

 

 

Balance Sheets

 

 

2

 

 

 

 

 

 

Statements of Operations and Other Comprehensive Income/(Loss)

 

 

3

 

 

 

 

 

 

Statements of Stockholders’ Equity

 

 

4

 

 

 

 

 

 

Statements of Cash Flows

 

 

5

 

 

 

 

 

 

Notes to the Unaudited Financial Statements

 

 

6-12

 

 

 
1

 

 

Chemrex Corporation Sdn. Bhd.

Balance Sheets

September 30, 2020 and December 31, 2019

Expressed in United States Dollars

(unaudited)

 

 

 

September 30,

 

 

December 31,

 

 

 

2020

 

 

2019

 

ASSETS

 

 

 

 

 

 

Current Assets

 

 

 

 

 

 

Inventories

 

$ 1,178,775

 

 

$ 1,315,627

 

Trade receivables

 

 

3,568,699

 

 

 

4,346,817

 

Other receivables, deposits and prepayments

 

 

7,154

 

 

 

73,295

 

Cash and bank balances

 

 

1,502,869

 

 

 

346,008

 

Total Current Assets

 

 

6,257,497

 

 

 

6,081,747

 

 

 

 

 

 

 

 

 

 

Property, plant and equipment, net

 

 

1,075,877

 

 

 

1,878,073

 

Other investments

 

 

229,129

 

 

 

147,882

 

Total Non-Current Assets

 

 

1,305,006

 

 

 

2,025,955

 

 

 

 

 

 

 

 

 

 

TOTAL ASSETS

 

$ 7,562,503

 

 

$ 8,107,702

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current Liabilities

 

 

 

 

 

 

 

 

Trade payables

 

$ 1,924,495

 

 

$ 3,163,122

 

Accrued liabilities and other payables

 

 

17,905

 

 

 

608,216

 

Borrowings

 

 

5,940

 

 

 

3,258

 

Tax payable

 

 

304,091

 

 

 

31,182

 

Total Current Liabilities

 

 

2,252,431

 

 

 

3,805,778

 

 

 

 

 

 

 

 

 

 

Deferred tax liabilities

 

 

3,061

 

 

 

3,107

 

Borrowings

 

 

-

 

 

 

3,912

 

Total Non-Current Liabilities

 

 

3,061

 

 

 

7,019

 

 

 

 

 

 

 

 

 

 

TOTAL LIABILITIES

 

 

2,255,492

 

 

 

3,812,797

 

 

 

 

 

 

 

 

 

 

Stockholders' Equity

 

 

 

 

 

 

 

 

Share capital

 

 

395,306

 

 

 

395,306

 

Accumulated other comprehensive loss

 

 

(82,246 )

 

 

(36,913 )

Accumulated surplus

 

 

4,993,951

 

 

 

3,936,512

 

Total Stockholders’ Equity

 

 

5,307,011

 

 

 

4,294,905

 

 

 

 

 

 

 

 

 

 

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY

 

$ 7,562,503

 

 

$ 8,107,702

 

   

The notes are an integral part of these unaudited financial statements.

 

 
2

 

  

Chemrex Corporation Sdn. Bhd.

Statements of Operations and Other Comprehensive Income/(Loss)

Expressed in United States Dollars

(Unaudited)

 

 

 

For the Nine Months Period Ended

 

 

 

September 30,

 

 

 

2020

 

 

2019

 

Revenue

 

$ 7,234,543

 

 

$ 11,424,657

 

 

 

 

 

 

 

 

 

 

Cost of revenue

 

 

(5,882,174 )

 

 

(9,837,243 )

 

 

 

 

 

 

 

 

 

Gross profit

 

 

1,352,369

 

 

 

1,587,414

 

 

 

 

 

 

 

 

 

 

Other income

 

 

759,437

 

 

 

58,990

 

 

 

 

 

 

 

 

 

 

Operating expenses - general and administrative

 

 

(694,475 )

 

 

(850,879 )

 

 

 

 

 

 

 

 

 

Profit from operations

 

 

1,417,331

 

 

 

795,525

 

 

 

 

 

 

 

 

 

 

Finance costs

 

 

(5,282 )

 

 

(18,465 )

 

 

 

 

 

 

 

 

 

Profit before provision for income taxes

 

 

1,412,049

 

 

 

777,060

 

 

 

 

 

 

 

 

 

 

Provision for income taxes

 

 

(354,610 )

 

 

(202,021 )

 

 

 

 

 

 

 

 

 

Net income

 

$ 1,057,439

 

 

$ 575,039

 

 

 

 

 

 

 

 

 

 

Other comprehensive income / (loss)

 

 

(45,333 )

 

 

(65,361 )

 

 

 

 

 

 

 

 

 

Total comprehensive income

 

$ 1,012,106

 

 

$ 509,678

 

 

 

 

 

 

 

 

 

 

Basic and diluted income per share of common stock

 

$ 0.66

 

 

$ 0.36

 

Weighted average number of shares of common stock outstanding

 

 

1,600,000

 

 

 

1,600,000

 

 

The notes are an integral part of these unaudited financial statements.

 

 
3

 

 

Chemrex Corporation Sdn. Bhd.

Statements of Stockholders’ Equity 

For the Period Ended September 30, 2020 and 2019

Expressed in United States Dollars

(Unaudited)

 

 

 

Share Capital

 

 

 

 

 

Accumulated

Other

 

 

Total

 

 

 

Number of

Shares

 

 

Amount

 

 

Accumulated

Surplus

 

 

Comprehensive

Income/(Loss)

 

 

Stockholders'

Equity

 

Balance - December 31, 2018/ January 1, 2019

 

 

1,600,000

 

 

$ 395,306

 

 

$ 3,396,153

 

 

$ (82,420 )

 

$ 3,709,039

 

Net income

 

 

-

 

 

 

-

 

 

 

575,039

 

 

 

-

 

 

 

575,039

 

Other comprehensive loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(65,361 )

 

 

(65,361 )

Balance - September 30, 2019

 

 

1,600,000

 

 

$ 395,306

 

 

$ 3,971,192

 

 

$ (147,781 )

 

$ 4,218,717

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance - December 31, 2019/ January 1, 2020

 

 

1,600,000

 

 

$ 395,306

 

 

$ 3,936,512

 

 

$ (36,913 )

 

$ 4,294,905

 

Net income

 

 

-

 

 

 

-

 

 

 

1,057,439

 

 

 

-

 

 

 

1,057,439

 

Other comprehensive expenses

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(45,333 )

 

 

(45,333 )

Balance - September 30, 2020

 

 

1,600,000

 

 

$ 395,306

 

 

$ 4,993,951

 

 

$ (82,246 )

 

$ 5,307,011

 

 

The notes are an integral part of these unaudited financial statements.

 

 
4

 

  

Chemrex Corporation Sdn. Bhd.

Statements of Cash Flows

Expressed in United States Dollars

(Unaudited)

 

 

 

For the Nine Months Period Ended

 

 

 

September 30,

 

 

 

2020

 

 

2019

 

CASH FLOWS FROM OPERATING ACTIVITIES:

 

 

 

 

 

 

Net income

 

$ 1,057,439

 

 

$ 575,039

 

Adjustment to reconcile profit to net cash from/(used in) operating activities:

 

 

 

 

 

 

 

 

Bad debts written off

 

 

-

 

 

 

1,324

 

Depreciation of property, plant and equipment

 

 

30,736

 

 

 

44,893

 

Dividend income

 

 

(4,850 )

 

 

(1,824 )

Gain on disposal of property, plant and equipment

 

 

(701,447 )

 

 

-

 

Finance costs

 

 

5,282

 

 

 

18,465

 

Operating profit before changes in working capital

 

 

387,160

 

 

 

637,897

 

 

 

 

 

 

 

 

 

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Inventories

 

 

117,065

 

 

 

(416,045 )

Trade receivables

 

 

717,805

 

 

 

(490,255 )

Other receivables, deposits and prepayments

 

 

65,040

 

 

 

(5,959 )

Trade payables

 

 

(1,226,262 )

 

 

1,721,560

 

Accrued liabilities and other payables

 

 

(581,176 )

 

 

274,652

 

Amount owing to Directors

 

 

-

 

 

 

(186,706 )

Tax payable

 

 

273,378

 

 

 

71,593

 

Net Cash (Used in)/Provided by Operating Activities

 

 

(246,990 )

 

 

1,606,737

 

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES:

 

 

 

 

 

 

 

 

Addition in other investments

 

 

(109,822 )

 

 

-

 

Dividend received

 

 

4,850

 

 

 

1,824

 

Proceeds from disposal of other investments

 

 

26,350

 

 

 

-

 

Proceeds from disposal of property, plant and equipment

 

 

1,467,865

 

 

 

-

 

Purchase of property, plant and equipment

 

 

(1,062 )

 

 

(931 )

Net Cash Provided by Investing Activities

 

 

1,388,181

 

 

 

893

 

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES:

 

 

 

 

 

 

 

 

Interests paid

 

 

(5,282 )

 

 

(18,465 )

Repayment of term loans

 

 

-

 

 

 

(258,059 )

Repayment of short-term borrowings

 

 

-

 

 

 

(499,004 )

Repayment of obligation under finance lease

 

 

(1,122 )

 

 

(5,009 )

Net Cash Used in Financing Activities

 

 

(6,404 )

 

 

(780,537 )

 

 

 

 

 

 

 

 

 

Effect of Exchange Rate Changes

 

 

22,074

 

 

 

(9,278 )

 

 

 

 

 

 

 

 

 

Net increase in cash and cash equivalents

 

 

1,156,861

 

 

 

817,815

 

Cash and cash equivalents, beginning of the year

 

 

346,008

 

 

 

(112,805 )

Cash and cash equivalents, end of the year

 

$ 1,502,869

 

 

$ 705,010

 

 

The notes are an integral part of these unaudited financial statements.

 

 
5

 

  

Chemrex Corporation Sdn. Bhd.

Notes to the Unaudited Financial Statements

September 30, 2020 and 2019
Expressed in United States Dollars

 

NOTE 1 - ORGANIZATION AND DESCRIPTION OF BUSINESS

 

Chemrex Corporation Sdn. Bhd. (“we,” “us,” “our,” the “Company,” or “CCSB”) is a private limited liability company, incorporated in Malaysia.

 

The registered office of business of the Company is located at 87-2, Jalan Pudu Ulu, 56100 Kuala Lumpur.

 

Chemrex wholesales chemicals and resins for the manufacturers in industrial, medical components and equipment industries with customers located across South East Asia, Middle East and South India.

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The Financial Statements and related disclosures have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The Financial Statements have been prepared using the accrual basis of accounting in accordance with Generally Accepted Accounting Principles (“GAAP”) of the United States and presented in United States dollars.

 

In the opinion of management, the consolidated balance sheet as of December 31, 2019 which has been derived from audited financial statements and these unaudited consolidated financial statements reflect all normal and recurring adjustments considered necessary to state fairly the results for the periods presented. The results for the nine months ended September 30, 2020 are not necessarily indicative of the results to be expected for the entire fiscal year ending December 31, 2020 or for any future period. 

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. The estimates and judgments will also affect the reported amounts for certain revenues and expenses during the reporting period. Actual results could differ from these good faith estimates and judgments.

 

Foreign Currency Translation and Re-measurement

 

The Company translates its foreign operations to U.S. dollar in accordance with ASC 830, “Foreign Currency Matters”.

 

Translation of amounts from the local currency of the Company into US$1.00 has been made at the following exchange rates for the respective years:

 

 

 

September 30, 2020

 

 

December 31, 2019

 

Year-end USD : MYR exchange rate

 

 

4.156

 

 

 

4.093

 

 

 

 

January 1, 2020 to

September 30, 2020

 

 

January 1, 2019 to

September 30, 2019

 

 

 

 

Period-end average USD : MYR exchange rate

 

 

4.234

 

 

 

4.135

 

 

 
6

 

 

The Company’s functional currency is Malaysian Ringgit (“MYR”) and reporting currency is the U.S. dollar.

 

The Company translates its records into U.S. dollar as follows:

 

 

·

Assets and liabilities at the rate of exchange in effect at the balance sheet date

 

·

Equities at historical rate

 

·

Revenue and expense items at the average rate of exchange prevailing during the period

 

Financial Instruments

 

The Company’s financial instruments consist primarily of cash and cash equivalents, accounts receivable, prepaid expenses and other current assets, accounts payable, accrued liabilities and other payable, deferred revenue and due to related parties. The carrying amounts of such financial instruments approximate their respective estimated fair value due to the short-term maturities and approximate market interest rates of these instruments.

 

Property, plant and equipment

 

Property, plant and equipment are recorded at cost. Depreciation is calculated using straight line method over the estimated useful lives of the assets. The useful lives are as follows:

 

Buildings

 

50 years

 

Equipment

 

5 years

 

Furniture and fittings

 

10 years

 

Motor vehicle

 

5 years

 

Office equipment

 

5 years

 

Renovation

 

10 years

 

Signboard

 

10 years

 

 

Leased assets are depreciated over the shorter of the lease term and their useful lives unless it is reasonably certain that the Company will obtain ownership by the end of the lease term. Freehold land is not depreciated. Property, plant and equipment under construction are not depreciated until the assets are ready for their intended use

 

Maintenance and repairs are charged to operations as incurred. Expenditures which substantially increase the useful lives of the related assets are capitalized. When properties are disposed of, the related costs and accumulated depreciation are removed from the accounts and any gain or loss is reported in the period the transaction takes place.

 

Accounting for the impairment of long-lived assets

 

The long-lived assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of assets may not be recoverable. It is reasonably possible that these assets could become impaired as a result of technology or other industry changes. Determination of recoverability of assets to be held and used is by comparing the carrying amount of an asset to future net undiscounted cash flows to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell. During the year ended September 30, 2020 and 2019, the Company did not impair any long-lived assets.

 

 
7

 

 

Inventories

 

Inventories consisting of products available for sell, are stated at the lower of cost or market value. Cost of inventory is determined using the weighted average method. Inventory reserve is recorded to write down the cost of inventory to the estimated market value due to slow-moving merchandise and damaged goods, which is dependent upon factors such as historical and forecasted consumer demand, and promotional environment. The Company takes ownership, risks and rewards of the products purchased. Write downs are recorded in cost of revenues in the Condensed Statements of Operations and Comprehensive Income.

 

Leases

 

In February 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2016-02, Leases, which was subsequently amended in 2018 by ASU 2018-10, ASU 2018-11 and ASU 2018-20 (collectively, Topic 842). Topic 842 will require the recognition of a right-of-use asset and a corresponding lease liability, initially measured at the present value of the lease payments, for all leases with terms longer than 12 months. For operating leases, the asset and liability will be expensed over the lease term on a straight-line basis, with all cash flows included in the operating section of the statement of cash flows. For finance leases, interest on the lease liability will be recognized separately from the amortization of the right-of-use asset in the statement of comprehensive income and the repayment of the principal portion of the lease liability will be classified as a financing activity while the interest component will be included in the operating section of the statement of cash flows. Topic 842 is effective for annual and interim reporting periods beginning after December 15, 2018. Early adoption is permitted. Upon adoption, leases will be recognized and measured at the beginning of the earliest period presented using a modified retrospective approach. Topic 842 allows for a cumulative-effect adjustment in the period the new lease standard is adopted and will not require restatement of prior periods.

 

Prior to January 1, 2019, the Company accounted for leases under ASC 840, Accounting for Leases. Effective July 1, 2019, the Company adopted the guidance of ASC 842, Leases, which requires an entity to recognize a right-of-use asset and a lease liability for virtually all leases. The Company adopted ASC 842 using a modified retrospective approach. As a result, the comparative financial information has not been updated and the required disclosures prior to the date of adoption have not been updated and continue to be reported under the accounting standards in effect for those periods.

 

Revenue Recognition

 

Revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services.

 

The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:

 

 

·

identify the contract with a customer;

 

·

identify the performance obligations in the contract;

 

·

determine the transaction price;

 

·

allocate the transaction price to performance obligations in the contract; and

 

·

recognize revenue as the performance obligation is satisfied.

 

The Company records revenue at point in time which is recognized upon goods delivered or services rendered.

 

 
8

 

 

Income Taxes and Deferred Taxes

 

Tax expense in profit or loss comprises current and deferred tax. Current tax and deferred tax are recognized in profit or loss except to the extent that it relates to a business combination or items recognized directly in equity or other comprehensive income.

 

Deferred tax is recognized using the liability method for all temporary differences between the carrying amounts of assets and liabilities in the statement of financial position and their tax bases. Deferred tax is not recognized for the temporary differences arising from the initial recognition of goodwill, the initial recognition of assets and liabilities in a transaction which is not a business combination and that affects neither accounting nor taxable profit or loss. Deferred tax is measured at the tax rates that are expected to be applied to the temporary differences when they reverse, based on the laws that have been enacted or substantively enacted by the end of the reporting period.

 

Recent Accounting Pronouncements

 

Management has considered all recent accounting pronouncements issued. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s financial statements.

 

NOTE 3 – TRADE RECEIVABLES

 

The Company has performed an analysis on all its trade receivables and determined that all amounts are collectible by the Company. As such, trade receivables are reflected as a current asset and no allowance for expected credit loss has been recorded as of September 30, 2020 and December 31, 2019. Total of $Nil and $1,324 of bad debts were written off for the period ended September 30, 2020 and September 30, 2019, respectively. The Company’s trade receivables consist of receivable from customers which are unrelated to the Company. The account receivables are non-interest bearing and is generally on 30 days to 90 days term. As of September 30, 2020 and December 31, 2019, the Company recorded $3,568,699 and $4,346,817 trade receivables, respectively.

 

NOTE 4 – OTHER RECEIVABLES, DEPOSITS AND PREPAYMENTS 

 

Other receivables, deposits and prepayments at September 30, 2020 and December 31, 2019 consist of the following:

 

 

 

September 30,

 

 

December 31,

 

 

 

2020

 

 

2019

 

 

 

 

 

 

 

 

Other receivables, deposits and prepayments

 

$ 7,154

 

 

$ 73,295

 

 

 
9

 

 

NOTE 5 – PROPERTY, PLANT AND EQUIPMENT

 

Property, plant and equipment at September 30, 2020 and December 31, 2019 consist of the following:

 

 

 

September 30,

 

 

December 31,

 

 

 

2020

 

 

2019

 

Cost:

 

 

 

 

 

 

Equipment

 

$ 43,357

 

 

$ 43,357

 

Furniture and fittings

 

 

83,373

 

 

 

83,373

 

Land and buildings

 

 

1,117,606

 

 

 

1,926,794

 

Motor vehicle

 

 

24,593

 

 

 

24,593

 

Office equipment

 

 

30,955

 

 

 

30,208

 

Renovation

 

 

105,743

 

 

 

105,448

 

Signboard

 

 

712

 

 

 

712

 

 

 

 

1,406,339

 

 

 

2,214,485

 

Less: accumulated depreciation

 

 

(264,338 )

 

 

(290,287 )

Foreign exchange translation

 

 

(66,124 )

 

 

(46,125 )

Property, plant and equipment, net

 

$ 1,075,877

 

 

$ 1,878,073

 

 

During the period ended September 30, 2020 and September 30, 2019, the Company recorded depreciation of $30,736 and $44,893, respectively.

 

During the period ended September 30, 2020, the Company disposed of a property at a consideration of $1,467,865 with a gain of disposal of $701,447.

 

NOTE 6 – OTHER INVESTMENTS

 

 

 

September 30,

 

 

December 31,

 

 

 

2020

 

 

2019

 

As of beginning of the year

 

$ 147,882

 

 

$ 67,157

 

Addition during the year

 

 

109,822

 

 

 

62,348

 

Disposal during the year

 

 

(26,350 )

 

 

-

 

Fair value gain

 

 

-

 

 

 

17,459

 

Foreign exchange translation

 

 

(2,225 )

 

 

918

 

As of end of the year

 

$ 229,129

 

 

$ 147,882

 

 

The other investments consist of investment in quoted shares in Malaysia.

 

NOTE 7 – TRADE PAYABLES

 

Trade payables at September 30, 2020 and December 31, 2019 were $1,924,495 and $3,163,122, respectively. Trade payables are amounts billed to the Company by suppliers for goods and services in the ordinary course of business. All amounts have short-term repayment terms and vary by supplier.

 

 
10

 

  

NOTE 8 - ACCRUED LIABILITIES AND OTHER PAYABLES

 

Accrued liabilities and other payables at September 30, 2020 and December 31, 2019 consist of the following:

 

 

 

September 30,

 

 

December 31,

 

 

 

2020

 

 

2019

 

Accrued liabilities and other payables

 

$ 17,905

 

 

$ 608,216

 

  

NOTE 9 – BORROWINGS

 

The Company’s borrowings as at September 30, 2020 and December 31, 2019 are as follows:

 

 

 

September 30,

 

 

December 31,

 

 

 

2020

 

 

2019

 

Finance lease liabilities - current

 

 

5,940

 

 

 

3,258

 

Finance lease liabilities – non-current

 

 

-

 

 

 

3,912

 

 

 

$ 5,940

 

 

$ 7,170

 

 

The Company purchased motor vehicles under a finance lease agreement with principal and interest payable monthly.

 

NOTE 10 - STOCKHOLDERS’ EQUITY

 

Ordinary shares

 

The Company has authorized share capital of MYR1,600,000. The holders of ordinary shares are entitled to receive dividends as declared from time to time and are entitled to one vote per share at meetings of the Company.

 

The Company has no stock option plan, warrants or other dilutive securities.

 

 
11

 

 

NOTE 11 – INCOME TAXES

 

The Company provides for income taxes under ASC 740, “Income Taxes. ASC 740 requires the use of an asset and liability approach in accounting for income taxes. Deferred tax assets and liabilities are recorded based on the differences between the financial statement and tax basis of assets and liabilities and the tax rates in effect when these differences are expected to reverse. It also requires the reduction of deferred tax assets by a valuation allowance if, based on the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized.

 

The Company is operating in Malaysia and is subject to the Malaysia Corporate Tax which is charged at the statutory income tax rate range is 24% on its assessable income. Under the amendment of Income Tax Act 1967 by the Finance Act 2019 and with effect from year of assessment 2020, companies with paid-up capital of MYR2.5 million or less, and with annual business income of not more than RM50 million are subject to Small and Medium Enterprise Corporate Tax at 17%  on chargeable income up to MYR600,000 (2019: MYR500,000) except for companies with investment holding nature or companies does not have gross income from business sources are subject to corporate tax at 24% on chargeable income.

 

NOTE 12 – SIGNIFICANT EVENTS

 

On 11 March 2020, the World Health Organization declared the Coronavirus (“Covid-19”) outbreak to be a pandemic, which has caused severe global social and economic disruptions and uncertainties, including markets where the Company operates or intends to operate. The Company is actively monitoring and managing its operations to respond to these changes, the Company does not consider it practicable to provide any quantitative estimate on the potential impact it may have on the Company as the outbreak continue to evolve as of the date of this report.

  

NOTE 13 - SUBSEQUENT EVENTS

 

Management has evaluated subsequent events through the date these financial statements were available to be issued. Based on our evaluation no material events have occurred that require disclosure.

 

 
12